HDAC inhibitor chidamide synergizes with venetoclax to inhibit the growth of diffuse large B-cell lymphoma via down-regulation of MYC, BCL2, and TP53 expression
Crossref DOI link: https://doi.org/10.1631/jzus.B2200016
Published Online: 2022-08-20
Published Print: 2022-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Luo, Cancan
Yu, Tiantian
Young, Ken H.
Yu, Li http://orcid.org/0000-0001-5307-8782
Text and Data Mining valid from 2022-08-01
Version of Record valid from 2022-08-01
Article History
Received: 11 January 2022
Accepted: 10 April 2022
First Online: 20 August 2022